The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Bai, Han ^a   Chen, Xiaokai ^a   Zhang, Lin ^a   Dou, Xiaoguang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemoprevention; Chronic pancreatitis; Sulindac

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CERULETIDE; GLI PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SONIC HEDGEHOG PROTEIN; SULINDAC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACINI LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CELL LOSS; CELL TYPE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FIBROSIS; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREATIC SATELLET CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; STROMAL FIBROSIS; WESTERN BLOTTING;

ACINAR CELLS; ACTINS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAERULEIN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PANCREAS; PANCREATITIS, CHRONIC; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX; SULINDAC; TREATMENT OUTCOME;

EID: 84865289194     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-115     Document Type: Article

References (38)

1. Reding T, et al. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis. Gut 2006, 55(8):1165-1173. 1856270, 16322109.
2. Ulmasov B, et al. Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. Am J Physiol Gastrointest Liver Physiol 2010, 299(1):G70-G80. 10.1152/ajpgi.00006.2010, 20413721.
3. Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 2008, 43(11):823-832. 10.1007/s00535-008-2249-7, 19012035.
4. Charrier AL, Brigstock DR. Connective tissue growth factor production by activated pancreatic stellate cells in mouse alcoholic chronic pancreatitis. Lab Invest 2010, 90(8):1179-1188. 10.1038/labinvest.2010.82, 2901405, 20368699.
5. Phillips PA, et al. Cell migration: a novel aspect of pancreatic stellate cell biology. Gut 2003, 52(5):677-682. 10.1136/gut.52.5.677, 1773645, 12692052.
6. Mews P, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 2002, 50(4):535-541. 10.1136/gut.50.4.535, 1773172, 11889076.
7. Talukdar R, Tandon RK. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol 2008, 23(1):34-41.
8. Yang L, et al. L-cysteine administration attenuates pancreatic fibrosis induced by TNBS in rats by inhibiting the activation of pancreatic stellate cell. PLoS One 2012, 7(2):e31807. 10.1371/journal.pone.0031807, 3281011, 22359633.
9. Kayed H, et al. Distribution of Indian hedgehog and its receptors patched and smoothened in human chronic pancreatitis. J Endocrinol 2003, 178(3):467-478. 10.1677/joe.0.1780467, 12967338.
10. Shinozaki S, et al. Indian hedgehog promotes the migration of rat activated pancreatic stellate cells by increasing membrane type-1 matrix metalloproteinase on the plasma membrane. J Cell Physiol 2008, 216(1):38-46. 10.1002/jcp.21372, 18286538.
11. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000, 69:145-182. 10.1146/annurev.biochem.69.1.145, 10966456.
12. Schlosser W, et al. Cyclooxygenase-2 is overexpressed in chronic pancreatitis. Pancreas 2002, 25(1):26-30. 10.1097/00006676-200207000-00008, 12131767.
13. Silva A, et al. COX-2 is not required for the development of murine chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011, 300(6):G968-G975. 10.1152/ajpgi.00497.2010, 21372163.
14. Polito F, et al. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. Br J Pharmacol 2010, 161(5):1002-1011. 10.1111/j.1476-5381.2010.00933.x, 2998682, 20977452.
15. Marshall TM, et al. Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E(2) in the spinal cord. Pain 2012, 153(1):86-94. 10.1016/j.pain.2011.09.021, 22030324.
16. Masuko K, et al. Prostaglandin E2 regulates the expression of connective tissue growth factor (CTGF/CCN2) in human osteoarthritic chondrocytes via the EP4 receptor. BMC Res Notes 2010, 3:5. 10.1186/1756-0500-3-5, 2826353, 20205862.
17. Chan MM, Moore AR. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol 2010, 184(11):6418-6426. 10.4049/jimmunol.0903816, 3032587, 20435922.
18. Roberts HR, et al. Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Carcinogenesis 2011, 32(11):1741-1747. 10.1093/carcin/bgr210, 21926111.
19. Hasan S, et al. Expression analysis of the prostaglandin E2 production pathway in human pancreatic cancers. Pancreas 2008, 37(2):121-127. 10.1097/MPA.0b013e31816618ba, 18665070.
20. Aoki H, et al. Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines. Am J Physiol Cell Physiol 2007, 292(1):C259-C268.
21. Seo SW, et al. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats. World J Gastroenterol 2007, 13(16):2298-2304.
22. Haanen C. Sulindac and its derivatives: a novel class of anticancer agents. Curr Opin Investig Drugs 2001, 2(5):677-683.
23. Willemer S, Elsasser HP, Adler G. Hormone-induced pancreatitis. Eur Surg Res 1992, 24(Suppl 1):29-39.
24. Yoo BM, et al. Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology 2005, 5(2-3):165-176.
25. Aghdassi AA, et al. Animal models for investigating chronic pancreatitis. Fibrogenesis Tissue Repair 2011, 4(1):26. 10.1186/1755-1536-4-26, 3274456, 22133269.
26. Neuschwander-Tetri BA, et al. Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci 2000, 45(4):665-674. 10.1023/A:1005423122127, 10759232.
27. Su KH, Cuthbertson C, Christophi C. Review of experimental animal models of acute pancreatitis. HPB (Oxford) 2006, 8(4):264-286.
28. Mahmoud NN, et al. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 1998, 19(1):87-91. 10.1093/carcin/19.1.87, 9472698.
29. Bai H, et al. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice. Carcinogenesis 2011, 32(11):1689-1696. 10.1093/carcin/bgr191, 21859833.
30. Seril DN, et al. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 2002, 23(6):993-1001. 10.1093/carcin/23.6.993, 12082021.
31. Tandon RK, Garg PK. Oxidative stress in chronic pancreatitis: pathophysiological relevance and management. Antioxid Redox Signal 2011, 15(10):2757-2766. 10.1089/ars.2011.4115, 21902596.
32. van Westerloo DJ, et al. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005, 166(3):721-728. 10.1016/S0002-9440(10)62293-6, 1602356, 15743784.
33. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes?. Acta Pharmacol Sin 2008, 29(11):1275-1288. 10.1111/j.1745-7254.2008.00889.x, 2631033, 18954521.
34. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5(10):749-759. 10.1038/nri1703, 16175180.
35. Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 2010, 20(1):65-71. 10.1016/j.gde.2009.11.004, 2821983, 20036794.
36. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899. 10.1016/j.cell.2010.01.025, 2866629, 20303878.
37. Carr MW, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 1994, 91(9):3652-3656. 10.1073/pnas.91.9.3652, 43639, 8170963.
38. Masamune A, et al. Differential roles of signaling pathways for proliferation and migration of rat pancreatic stellate cells. Tohoku J Exp Med 2003, 199(2):69-84. 10.1620/tjem.199.69, 12705352.